Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass?

被引:49
作者
Wan, S
LeClerc, JL
Huynh, CH
Schmartz, D
DeSmet, JM
Yim, APC
Vincent, JL
机构
[1] Free Univ Brussels, Erasme Hosp, Dept Cardiac Surg, B-1050 Brussels, Belgium
[2] Free Univ Brussels, Erasme Hosp, Dept Anesthesiol, B-1050 Brussels, Belgium
[3] Free Univ Brussels, Erasme Hosp, Dept Intens Care, B-1050 Brussels, Belgium
关键词
D O I
10.1016/S0022-5223(99)70382-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The mechanism involved in the endotoxemia frequently recognized during cardiopulmonary bypass remains unclear. It has also been suggested that endotoxin levels were higher in steroid-pretreated patients undergoing cardiopulmonary bypass. Methods: Twenty patients undergoing cardiopulmonary bypass were randomly pretreated with steroids (methylprednisolone, 30 mg/kg or placebo. Blood samples for endotoxin measurement were drawn simultaneously from the superior and inferior venae cavae before heparin administration, 5 and 50 minutes after the onset of bypass, 5 minutes after aortic declamping, at the end of I,a pass, and 1, 2, and 20 hours after the end of cardiopulmonary bypass. Results: The perioperative variables in the tyro groups were similar. Blood endotoxin levels were higher in the inferior vena cava than in the superior vena cava immediately after the onset of bypass. Endotoxin levels in inferior vena cava blood were significantly lower in steroid-pretreated patients than those in patients not receiving steroids. Conclusions: Endotoxin is released during cardiopulmonary bypass from the region drained by the inferior vena cava, Steroid pretreatment mag actually reduce endotoxin release during bypass.
引用
收藏
页码:1004 / 1008
页数:5
相关论文
共 28 条
  • [1] Andersen L W, 1989, J Cardiothorac Anesth, V3, P544, DOI 10.1016/0888-6296(89)90150-6
  • [2] ASSOCIATION BETWEEN GASTRIC INTRAMUCOSAL PH AND SPLANCHNIC ENDOTOXIN, ANTIBODY TO ENDOTOXIN, AND TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATIONS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS
    ANDERSEN, LW
    LANDOW, L
    BAEK, L
    JANSEN, E
    BAKER, S
    [J]. CRITICAL CARE MEDICINE, 1993, 21 (02) : 210 - 217
  • [3] ANDERSEN LW, 1987, J THORAC CARDIOV SUR, V93, P115
  • [4] BennettGuerrero E, 1997, JAMA-J AM MED ASSOC, V277, P646
  • [5] FAST-TRACK RECOVERY OF THE CORONARY-BYPASS PATIENT
    ENGELMAN, RM
    ROUSOU, JA
    FLACK, JE
    DEATON, DW
    HUMPHREY, CB
    ELLISON, LH
    ALLMENDINGER, PD
    OWEN, SG
    PEKOW, PS
    [J]. ANNALS OF THORACIC SURGERY, 1994, 58 (06) : 1742 - 1746
  • [6] INFLUENCE OF STEROIDS ON COMPLEMENT AND CYTOKINE GENERATION AFTER CARDIOPULMONARY BYPASS
    ENGELMAN, RM
    ROUSOU, JA
    FLACK, JE
    DEATON, DW
    KALFIN, R
    DAS, D
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (03) : 801 - 804
  • [7] FINK MP, 1991, ARCH SURG-CHICAGO, V126, P211
  • [8] Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery
    HamiltonDavies, C
    Barclay, R
    Cardigan, RA
    McDonald, SJ
    Purdy, G
    Machin, SJ
    Webb, AR
    [J]. CHEST, 1997, 112 (05) : 1189 - 1196
  • [9] ENDOTOXIN RELEASE AND TUMOR-NECROSIS-FACTOR FORMATION DURING CARDIOPULMONARY BYPASS
    JANSEN, NJG
    VANOEVEREN, W
    GU, YJ
    VANVLIET, MH
    EIJSMAN, L
    WILDEVUUR, CRH
    [J]. ANNALS OF THORACIC SURGERY, 1992, 54 (04) : 744 - 748
  • [10] JANSEN NJG, 1991, J THORAC CARDIOV SUR, V102, P515